Lee Y S, Chung I S, Lee I R, Kim K H, Hong W S, Yun Y S
Laboratory of Experimental Pathology, Korea Cancer Center Hospital KAERI Seoul, Korea.
Anticancer Res. 1997 Jan-Feb;17(1A):323-31.
In the present study an acidic polysaccharide ginsan, with a molecular weight of 150,000, devoid of lectin properties, was purified from Panax ginseng C.A. Meyer (Araliaceae). Ginsan induced the proliferation of T cells and B cells. Spleen cells became cytotoxic to a wide range of tumor cells without major histocompatibility complex-restriction after 4 or 5 days culture in vitro with ginsan. For the generation of these ginsan-activated killer (AK) cells adherent macrophages and CD4+ cells were needed as accessory cells. The generation of ginsan-AK cells was blocked in the presence of anti-IL-2, anti-IFN gamma, anti-IL-1 or anti-TNF alpha antibodies, showing the importance of these cytokines in the process. The surface phenotypes of the 4 day-cultured ginsan-AK cells was Thy1+, AsGM1+, CD8+, which is distinct from rIL-2 induced lymphokine activated killer (LAK) cells that were CD8. The ginsan also activated macrophages to produce reactive nitrogen intermediates and become tumoricidal. It also exhibited significant in vivo antitumor activity against B16 melanoma cells lines, and in the benzo(a)pyrene-induced autochthonous lung tumor model, at much lower doses than the maximum tolerate doses. Indeed, no mice died, which injected with ginsan at 1g/kg body weight intraperitoneally. In conclusion, 'ginsan' could potentially be an ideal nontoxic antineoplastic immunostimulator by activating multiple effector arms of the immune system.
在本研究中,从五加科人参(Panax ginseng C.A. Meyer)中纯化出一种酸性多糖人参聚糖,其分子量为150,000,不具有凝集素特性。人参聚糖可诱导T细胞和B细胞增殖。脾细胞在体外与人参聚糖培养4或5天后,对多种肿瘤细胞产生细胞毒性,且不受主要组织相容性复合体限制。为生成这些人参聚糖激活的杀伤(AK)细胞,需要黏附性巨噬细胞和CD4 +细胞作为辅助细胞。在存在抗IL - 2、抗IFNγ、抗IL - 1或抗TNFα抗体的情况下,人参聚糖 - AK细胞的生成受到阻断,表明这些细胞因子在该过程中的重要性。培养4天的人参聚糖 - AK细胞的表面表型为Thy1 +、AsGM1 +、CD8 +,这与rIL - 2诱导的淋巴因子激活的杀伤(LAK)细胞(CD8)不同。人参聚糖还可激活巨噬细胞产生反应性氮中间体并具有杀肿瘤作用。在体内,它对B16黑色素瘤细胞系以及在苯并(a)芘诱导的自发性肺癌肿瘤模型中也表现出显著的抗肿瘤活性,且剂量远低于最大耐受剂量。实际上,腹腔注射1g/kg体重人参聚糖的小鼠无死亡情况。总之,“人参聚糖”通过激活免疫系统的多个效应臂,有可能成为一种理想的无毒抗肿瘤免疫刺激剂。